Russian Study of the Efficacy and Safety of Tarka in Patients With Hypertension

Completed · Phase 4

Conditions studied: Hypertension

In brief

This study will investigate antihypertensive activity and safety profile of Tarka in Russian hypertension patients by ambulatory blood pressure measurement (ABPM)

Key facts

Study ID

NCT00235001

Run by

Abbott

People needed

120

Starts

2004-06-01

Last updated by the study team

2008-07-10

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Hypertension

You may not qualify if…

• SBP > 180 mm Hg, DBP > 114 mm Hg
• Subject has a hypersensitivity to trandolapril or verapamil

Where it is running

• Global Medical Information-Abbott — North Chicago, Illinois, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.